Bristol-Myers Squibb Holdings Ireland Unlimited Company;Pfizer Inc.
发明人:
申请号：
EP20151141.7
公开号：
EP3662899A1
申请日:
2011.02.24
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides tablets comprising a composition comprising crystalline apixaban particles having a mean particle size equal to or less than about 85 µm and a D90 equal to or less than 85 µm and further comprising a pharmaceutically acceptable diluent or carrier as well as processes for producing the same.
